We are live on ! Find out more
STIM icon

Neuronetics

67 hedge funds and large institutions have $31.5M invested in Neuronetics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

2% more funds holding

Funds holding: 6667 (+1)

1.05% less ownership

Funds ownership: 59.43%58.38% (-1%)

28% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 25

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

63% less capital invested

Capital invested by funds: $84.2M → $31.5M (-$52.7M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $7K

Holders
67
Holders Change
+1
Holders Change %
+1.52%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
8
Increased
18
Reduced
25
Closed
7
Calls
Puts
$7K
Net Calls
-$7K
Net Calls Change
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Archon Capital Management
Washington
$4.45M -$184K -63,828 -3%
CC
2
Cannell Capital
Wyoming
$4.29M -$236K -81,953 -3%
KLC
3
Kent Lake Capital
Nevada
$3.13M +$2.07M +716,951 +70%
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.34M
FWC
5
First Washington Corp
Washington
$2.29M +$1.73M +599,455 +89%
SAM
6
Silvercrest Asset Management
New York
$2.15M +$44.3K +15,344 +1%
Balyasny Asset Management
7
Balyasny Asset Management
Illinois
$2.06M -$72.9K -25,273 -2%
First Eagle Investment Management
8
First Eagle Investment Management
New York
$1.87M +$750K +260,000 +33%
GIPM
9
G2 Investment Partners Management
New York
$1.23M +$69.9K +24,228 +4%
MAG
10
Millrace Asset Group
Pennsylvania
$987K -$601K -208,334 -28%
BlackRock
11
BlackRock
New York
$687K +$3.32K +1,150 +0.3%
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$587K +$181K +62,628 +24%
Renaissance Technologies
13
Renaissance Technologies
New York
$580K +$515K +178,700 +125%
DCM
14
DAFNA Capital Management
California
$565K
Geode Capital Management
15
Geode Capital Management
Massachusetts
$537K +$33K +11,426 +4%
BFM
16
Boothbay Fund Management
New York
$334K +$67.9K +23,527 +15%
HighTower Advisors
17
HighTower Advisors
Illinois
$285K
Assenagon Asset Management
18
Assenagon Asset Management
Luxembourg
$244K +$151K +52,450 +63%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$231K -$54.6K -18,936 -13%
Citadel Advisors
20
Citadel Advisors
Florida
$188K +$36.8K +12,764 +14%
State Street
21
State Street
Massachusetts
$184K
DWT
22
Dorsey & Whitney Trust
South Dakota
$173K +$136K +47,228 +97%
BCM
23
Bridgeway Capital Management
Texas
$149K
EIM
24
Essex Investment Management
Massachusetts
$149K +$238K +82,668 New
GI
25
GAMCO Investors
Connecticut
$144K +$120K +41,500 +108%

STIM Hedge Fund Activity: Q2 2024 in Review

67 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q2 2024, worth a combined $31.5M — down 63% from $84.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new STIM positions and 7 closed out — a net gain of 1 holder — while 18 added to existing stakes and 25 trimmed.

The largest buyer was Kent Lake Capital, adding an estimated $2.07M. The largest seller was Divisadero Street Capital Management, cutting an estimated $4.29M.

  • 67 institutional investors held Neuronetics (STIM) as of Q2 2024, up from 66 in Q1 2024.
  • Funds reported $31.5M of Neuronetics stock for Q2 2024, down 63% quarter-over-quarter.
  • 8 funds opened new Neuronetics positions in Q2 2024 and 7 closed out, a net change of +1 holder.
  • The largest Neuronetics buyer in Q2 2024 was Kent Lake Capital, an estimated $2.07M added.
  • The largest Neuronetics seller in Q2 2024 was Divisadero Street Capital Management, an estimated $4.29M sold.

Based on aggregated 13F filings for Q2 2024.